tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Reni Benjamin, 194 are a BUY (86.22%), 30 are a HOLD (13.33%), 1 are a SELL (0.44%).
Analyst Reni Benjamin, currently employed at JMP, carries an average stock price target met ratio of 42.32% that have a potential upside of 46.46% achieved within 159 days.
Reni Benjamin’s has documented 406 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SMMT, Summit Therapeutics PLC at 20-Oct-2025.
Analyst best performing recommendations are on SANA (SANA BIOTECHNOLOGY).
The best stock recommendation documented was for SANA (SANA BIOTECHNOLOGY) at 6/24/2025. The price target of $5 was fulfilled within 29 days with a profit of $2.03 (68.35%) receiving and performance score of 23.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$10
$2.12 (26.90%)
$22
2 months 18 days ago
(11-Aug-2025)
1/13 (7.69%)
$2.78 (38.50%)
174
Hold
$13
$5.12 (64.97%)
$17
2 months 18 days ago
(11-Aug-2025)
0/8 (0%)
$5.78 (80.06%)
Buy
$48
2 months 19 days ago
(10-Aug-2025)
3/8 (37.5%)
$25.45 (112.86%)
192
Hold
$14
$6.12 (77.66%)
$17
5 months 28 days ago
(01-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Buy
$29
$21.12 (268.02%)
$30
5 months 28 days ago
(01-May-2025)
0/21 (0%)
$19.7 (211.83%)
Which stock is Reni Benjamin is most bullish on?
Which stock is Reni Benjamin is most reserved on?
What Year was the first public recommendation made by Reni Benjamin?
